Влияние различных факторов на эффективность самоконтроля при сахарном диабете

1. Karter AJ, Ackerson LM, Darbinian JA et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med 2001; 111: 1–9.
2. Welschen L, Bloemendal E, Nijpels G et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 2005; 28: 1510–7.
3. Skovlund SE, Peyrot M, on behalf of the DAWN International Advisory Panel. The Diabetes Attitudes, Wishes, and Needs (DAWN) program: a new approach to improving outcomes of diabetes care. Diabetes Spectrum 2005; 18: 136–42.
4. Jansen JP. Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons. Curr Med Res Opin 2006; 22: 671–81.
5. Heisler M, Piette JD, Spencer M et al. The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management. Diabetes Care 2005; 28: 816–22.
6. American Diabetes Association: Standards of medical care in diabetes-2010. Diabetes Care 2010; 33 (Suppl. 1): S11–S61.
7. American Association of Diabetes Educators: AADE guidelines for the practice of diabetes self-management education and training (DSME/T) 2009 [article online]; http://www.diabeteseducator.org/export/sites/aade/_resources/pdf/PracticeGuidelines2009.pdf. Accessed 14 March 2010.
8. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой. Вып. 5. М., 2009.
9. Davidson PC et al. Abstracts from the 64th Scientific Sessions of the American Diabetes Association. Orlando, Florida, 2004; Abstract, p. 430.
10. Karter AJ, Parker MM, Moffet HH et al. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care 2006; 29: 1757–63.
11. Stratton IM, Adler AI, Neil AW et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405–12.
12. The DCCT Research Group: The effect of intensive treatment on the development and progression of long-term complications in type 1 diabetes. N Engl J Med 1993; 329: 977–86.
13. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 2000; 23: B21–B29.
14. The UKPDS Study Group: Effort of intensive blood glucose control with insulin and sulfonylureas on insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53.
15. The DCCT Research Group: Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 1991; 90: 450–9.
16. Cox DJ, Gonder-Frederick L, Ritterband L et al: Prediction of severe hypoglycemia. Diabetes Care 2007; 30: 1370–3.
17. http://www.iso.org
18. Newman JD; Turner AP. Home blood glucose biosensors: a commercial perspective. Biosens Bioelectron 2005; 20: 2435–53.
19. Turner AP. Biosensors – sense and sensitivity. Science 2000; 290: 1315–7.
20. Hiratsuka A, Fujisawa K, Muguruma H. Amperometric biosensor based on glucose dehydrogenase and plasma-polymerized thin films. Anal Sci 2008; 24: 483–6.
21. D'Costa EJ, Higgins IJ, Turner AP. Quinoprotein glucose dehydrogenase and its application in an amperometric glucose sensor. Biosensors 1986; 2: 71–87.
22. Heller A, Feldman B. Electrochemical glucose sensors and their applications in diabetes management. Chem Rev 2008; 108: 2482–505.
23. Bankar SB, Bule MV, Singhal RS, Ananthanarayan L. Glucose oxidase – an overview. Biotechnol Adv 2009; 27: 489–501.
24. Yoo EH, Lee SY. Glucose Biosensors: an Overview of Use in Clinical Practice. Sensors 2010; 10: 4558–76.
25. Institute for Safe Medication Practices, Be aware of false glucose results with point-of-care testing. ISMP Medication Safety Alert! 2005; 10 (18).
26. Janssen W et al. Positive Interference of Icodextrin metabolites in some enzymatic glucose methods. Clinical Chemistry 1998; 44 (11): 2379–80.
27. http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PatientAlerts/ucm177189.htm
28. Ellison JM, Stegmann JM, Colner SL et al. Rapid Changes in Postprandial Blood Glucose Produce Concentration Differences at Finger, Forearm, and Thigh Sampling Sites. Diabetes Care 2002; 25: 961–4.
29. Bina DM et al. Clinical impact of prandial state, exercise, and site preparation on the equivalence of alternative-site blood glucose testing. Diabetes Care 2003; 26: 981–5.
30. Raine CH. 3rd Self-monitored blood glucose: a common pitfall. Endocr Pract 2003; 9 (9): 137–9.
31. Kristensen GB, Nerhus K, Thue G, Sandberg S. Standardized evaluation of instruments for self-monitoring of blood glucose by patients and a technologist. Clin Chem 2004; 50: 1068–71.
32. Baum JM, Monhaut NM, Parker DR, Price CP. Improving the quality of self-monitoring blood glucose measurement: a study in reducing calibration errors. Diabetes Technol Ther 2006; 8: 347–57.
33. Raine CH, Schrock LE, Edelman SV et al. Significant insulin dose errors may occur if blood glucose results are obtained from miscoded meters. J Diabetes Sci Technol 2007; 2: 205–10.

Ю.А.Редькин, В.В.Богомолов

ГУ Московский областной научно-исследовательский клинический институт им. М.Ф.Владимирского